Trinity Biotech (TRIB) Shares Outstanding (2017 - 2024)
Trinity Biotech (TRIB) has disclosed Shares Outstanding for 8 consecutive years, with $359.2 million as the latest value for Q4 2024.
- Quarterly Shares Outstanding rose 134.29% to $359.2 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $359.2 million through Dec 2024, up 134.29% year-over-year, with the annual reading at $359.2 million for FY2024, 134.29% up from the prior year.
- Shares Outstanding hit $359.2 million in Q4 2024 for Trinity Biotech, up from $153.3 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $359.2 million in Q4 2024 to a low of $83.6 million in Q4 2020.
- Historically, Shares Outstanding has averaged $166.4 million across 5 years, with a median of $152.4 million in 2022.
- Biggest five-year swings in Shares Outstanding: changed 0.0% in 2020 and later surged 134.29% in 2024.
- Year by year, Shares Outstanding stood at $83.6 million in 2020, then changed by 0.0% to $83.6 million in 2021, then soared by 82.32% to $152.4 million in 2022, then increased by 0.58% to $153.3 million in 2023, then skyrocketed by 134.29% to $359.2 million in 2024.
- Business Quant data shows Shares Outstanding for TRIB at $359.2 million in Q4 2024, $153.3 million in Q4 2023, and $152.4 million in Q4 2022.